ArticleGene therapy2021

Use of CRISPR/Cas9-mediated disruption of CNS cell type genes to profile transduction of AAV by neonatal intracerebroventricular delivery in mice.

Tess Torregrosa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.